Quarterly Results Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
6,046.87
3,264.44
3,256.20
3,387.55
3,433.80
3,244.18
3,062.96
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
6,046.87
3,264.44
3,256.20
3,387.55
3,433.80
3,244.18
3,062.96
Raw Material Cost
722.50
732.47
794.78
746.37
774.36
685.77
754.31
Purchase of Finished goods
620.45
581.34
344.74
418.15
443.08
360.03
210.80
(Increase) / Decrease In Stocks
-78.44
-298.23
-50.57
-80.28
-147.36
64.28
30.42
Employee Cost
1,086.26
762.75
736.57
788.49
786.57
710.44
700.96
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
1,336.55
905.59
869.66
914.59
975.23
835.45
862.12
Total Expenditure (Excl Depreciation)
3,687.32
2,683.92
2,695.18
2,787.32
2,831.88
2,655.97
2,558.61
Operating Profit (PBDIT) excl Other Income
2,359.55
580.52
561.02
600.23
601.92
588.21
504.35
Other Income
200.63
26.44
11.69
31.13
39.42
31.49
773.17
Operating Profit (PBDIT)
2,560.18
606.96
572.71
631.36
641.34
619.70
1,277.52
Interest
66.46
58.23
66.71
52.29
48.48
39.58
148.56
Exceptional Items
-1,385.12
-323.23
-372.82
0.00
0.00
0.00
-422.41
Gross Profit (PBDT)
1,108.60
225.50
133.18
579.07
592.86
580.12
682.17
Depreciation
141.20
129.93
125.21
122.74
120.28
117.79
151.34
Profit Before Tax
967.40
95.58
7.97
456.33
472.57
462.33
530.83
Tax
356.97
48.61
3.59
108.30
118.09
122.10
1,769.47
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
610.43
46.97
4.38
348.03
354.49
340.24
-1,238.65
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
24.38
Net Profit
610.43
46.97
4.38
348.03
354.49
340.24
-1,214.27
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.08
0.10
-0.27
0.07
0.27
-0.03
4.01
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
610.35
46.87
4.65
347.96
354.21
340.27
-1,218.28
Equity Capital
28.22
28.22
28.22
28.22
28.22
28.22
28.22
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
21.63
1.66
0.16
12.33
12.55
12.06
-43.17
Diluted Earnings per share
21.62
1.66
0.16
12.33
12.55
12.06
-43.17
Operating Profit Margin (Excl OI)
39.3%
18.98%
17.42%
18.18%
17.7%
18.25%
16.72%
Gross Profit Margin
18.47%
7.37%
4.14%
17.54%
17.43%
18.0%
22.62%
PAT Margin
10.17%
1.54%
0.14%
10.54%
10.42%
10.56%
-41.07%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 85.23% vs 0.25% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 1,202.22% vs 907.96% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is 306.45% vs 3.48% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is 14.13% vs -12.71% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Glenmark Pharma With
Figures in Cr
Consolidate Quarterly Results
Change(INR)
Change(%)
Net Sales
6,046.87
0
6,046.87
Other Operating Income
0.00
0.00
0.00
Total Operating income
6,046.87
0
6,046.87
Raw Material Cost
722.50
0
722.50
Purchase of Finished goods
620.45
0
620.45
(Increase) / Decrease In Stocks
-78.44
0
-78.44
Employee Cost
1,086.26
0
1,086.26
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
1,336.55
0.00
1,336.55
Total Expenditure (Excl Depreciation)
3,687.32
0
3,687.32
Operating Profit (PBDIT) excl Other Income
2,359.55
0.00
2,359.55
Other Income
200.63
0
200.63
Operating Profit (PBDIT)
2,560.18
0
2,560.18
Interest
66.46
0
66.46
Exceptional Items
-1,385.12
0
-1,385.12
Gross Profit (PBDT)
1,108.60
0
1,108.60
Depreciation
141.20
0
141.20
Profit Before Tax
967.40
0
967.40
Tax
356.97
0
356.97
Provisions and contingencies
0.00
0
0.00
Profit After Tax
610.43
0
610.43
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
610.43
0
610.43
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.08
0
0.08
Other related items
0.00
0.00
0.00
Consolidated Net Profit
610.35
0
610.35
Equity Capital
28.22
0
28.22
Face Value
1.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
21.63
0
21.63
Diluted Earnings per share
21.62
0
21.62
Operating Profit Margin (Excl OI)
39.30%
0%
0.00
39.30%
Gross Profit Margin
18.47%
0%
0.00
18.47%
PAT Margin
10.17%
0%
0.00
10.17%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 6,046.87 Cr
in Sep 2025Figures in Cr
QoQ Growth in quarter ended Sep 2025 is 85.23% vs 0.25% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 76.10% vs 7.06% in Sep 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 610.35 Cr
in Sep 2025Figures in Cr
QoQ Growth in quarter ended Sep 2025 is 1,202.22% vs 907.96% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 72.31% vs 532.23% in Sep 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2,359.55 Cr
in Sep 2025Figures in Cr
QoQ Growth in quarter ended Sep 2025 is 306.45% vs 3.48% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 292.00% vs 30.21% in Sep 2024
Quarterly - Interest
Interest 66.46 Cr
in Sep 2025Figures in Cr
QoQ Growth in quarter ended Sep 2025 is 14.13% vs -12.71% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 37.09% vs -60.09% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 39.30%
in Sep 2025Figures in %
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
